The ATRX exon 20--25 deletion seen in this tumor from a patient diagnosed at a late age (84 months) is expected to be in frame but is somewhat different from the other implicated in-frame fusions in this study, given a more C-terminal location with retention of the nuclear localization signal and DAXX domain. The gene discussed is ATRX; the disease is neoplasm.